DaVita
DaVita is a leading kidney care provider operating 3,262 outpatient dialysis centers across the US and 14 countries, serving approximately 296,300 patients with dialysis treatments, integrated kidney care programs, and value-based care arrangements for health plans and providers.
- Company typePublic
- Founded1999
- HeadquartersDenver, United States
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingServices
What DaVita does
DaVita Inc. is a leading kidney care provider operating 3,262 outpatient dialysis centers across the United States and 14 international countries, serving approximately 296,300 patients as of March 2026. Founded in 1999 and headquartered in Denver, Colorado, the company is publicly traded on NYSE under ticker DVA. DaVita delivers in-center hemodialysis, in-center nocturnal dialysis, home hemodialysis, and peritoneal dialysis, alongside transplant support services and integrated kidney care programs operated under the DaVita Integrated Kidney Care (IKC) and VillageHealth brands. The company also operates DaVita Clinical Research, DaVita Physician Solutions, and the DaVita Venture Group for strategic investments.
DaVita's technology stack includes AI-powered monitoring systems that flag treatment complications for proactive clinical intervention, an FDA-approved personalized dosing tool that generates medication recommendations from individual patient lab values, and predictive analytics for CKD progression under its integrated care programs. The company recently launched X9, an FDA-cleared ultrasound-guided cannulation device developed through its partnership with ExploraMed, and partners with Linea AI for congestive heart failure management. DaVita also operates the MedSleuth transplant software platform acquired in January 2022.
Revenue is generated primarily through contracted dialysis treatment services reimbursed by Medicare, Medicaid, and commercial health plans, supplemented by value-based care arrangements (shared savings and fully delegated contracts) managing over $5 billion in medical costs, and ancillary services including laboratory and pharmacy management. Berkshire Hathaway holds approximately 45% ownership as the largest shareholder, with the remainder distributed across public float. DaVita's customer segments span end-stage renal disease patients, chronic kidney disease populations, health plans, nephrologists, hospitals, and skilled nursing facilities.
DaVita firmographics
Firmographics- Name
- DaVita
- Legal name
- DaVita Inc.
- Website
- https://davita.com
- Company type
- Public
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- DaVita is a leading kidney care provider operating 3,262 outpatient dialysis centers across the US and 14 countries, serving approximately 296,300 patients with dialysis treatments, integrated kidney care programs, and value-based care arrangements for health plans and providers.
- Ownership category
- akta.pro rank
DaVita industry classification
Industry- Product category
- Dialysis and Kidney Care Services
- NAICS
- Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Outpatient Dialysis & Kidney Care Centers (HLAFABAE)
- akta.pro secondary industries
- Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC), Home Dialysis Programs (Home HD/PD Training & Support) (HLAKAHAK), Infusion & Home Infusion Pharmacy Services (HLAFALAG)
Keywords
Where DaVita is headquartered
LocationHeadquarters
- HQ city
- Denver
- HQ country
- United States
- HQ region
- North America
Offices11 records
Markets served
DaVita business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Dialysis Treatment Services: Core revenue from outpatient dialysis treatments and related kidney care services provided at over 3,262 centers globally
- Integrated Kidney Care / Value-Based Care: Value-based care arrangements including shared savings, fully delegated contracts, and traditional fee-for-service under DaVita IKC and VillageHealth brands. Company manages over $5 billion in related medical costs.
- Ancillary Services: Laboratory services, pharmacy management, and other ancillary healthcare services supporting dialysis patients
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | Healthcare services provided through contracted health plan and government payer reimbursement rates |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
DaVita product offering
Product offeringCore offering
DaVita operates outpatient dialysis centers delivering in-center hemodialysis, in-center nocturnal dialysis, peritoneal dialysis, and home hemodialysis for patients with chronic kidney disease and end-stage renal disease. The company also provides integrated kidney care (DaVita IKC / VillageHealth), care coordination, physician solutions, transplant support via MedSleuth software, and ancillary lab and pharmacy services across the U.S. and 14 international markets.
Product overview
DaVita is a healthcare provider specializing in kidney care services, operating a platform-plus-services model centered on dialysis treatment delivery. The core product is DaVita Kidney Care, providing in-center and home dialysis services through 3,262 outpatient dialysis centers globally. Supporting the core dialysis services are integrated care programs under DaVita Integrated Kidney Care (IKC) and VillageHealth brands, which provide care coordination, predictive analytics, and chronic disease management across the kidney disease continuum. The company also operates adjacent services including DaVita Clinical Research, DaVita Physician Solutions, and DaVita Venture Group for strategic investments. Patient-facing offerings include Kidney Smart education classes, care coordination services, and the acquired MedSleuth transplant software. International operations span 14 countries under DaVita International. The company serves approximately 296,300 patients at its outpatient dialysis centers.
Differentiator
Problem solved
Functional benefit
Brands
- VillageHealth: Integrated kidney care program for patients in earlier stages of chronic kidney disease or who do not dialyze with DaVita, operating alongside DaVita IKC
- DaVita Venture Group
- Kidney Smart
- DaVita HealthCare Partners
Products and services
- DaVita Kidney Care Core outpatient dialysis treatment services for patients with chronic kidney disease and end-stage renal disease, delivered through DaVita-operated centers in the U.S. and 14 countries.
- DaVita Integrated Kidney Care (IKC) Coordinated care program for CKD and ESRD patients covering care coordination, predictive analytics for early intervention, patient education, and collaboration with nephrologists and health plans.
- VillageHealth Chronic care management brand for patients in earlier stages of CKD or those who do not receive dialysis through DaVita, operating within DaVita IKC.
- Home Dialysis Home-based treatment options including home hemodialysis and peritoneal dialysis (PD) for patients who prefer treatment at home while maintaining clinical quality.
- Kidney Smart Classes Free kidney disease education classes covering causes, symptoms, treatment options, diet and nutrition, and insurance navigation, taught by DaVita dietitians.
- DaVita Clinical Research Clinical research division conducting studies to improve kidney care treatments, patient outcomes, and new therapeutic approaches in collaboration with academic institutions.
- DaVita Physician Solutions Physician-facing offering including medical directorships, joint ventures, clinical programs, and tools for nephrologists and healthcare providers.
- DaVita International International kidney care operations providing dialysis services and integrated kidney care across 14 countries outside the United States.
- MedSleuth Transplant software acquired by DaVita to streamline the transplant process, increase transplantation rates, and improve patient outcomes.
- DaVita Venture Group Strategic investment and venture capital arm making investments in healthcare innovation including tech-enabled services, home treatments, value-based care, digital health with AI, and life sciences.
Quantifiable outcome
- 25% lower hospitalization rate than industry average for integrated kidney care patients
- +6 more outcomes
Companies that use DaVita
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
DaVita technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability8 records
Feature4 records
DaVita partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Elara CaringcoreDaVita invested $200 million for a minority stake in Elara Caring alongside Ares Management's Private Equity Group. The partnership aims to develop an in-home support model for patients with chronic kidney disease, potentially reducing care costs. DaVita serves in an advisory capacity as Elara Caring develops a kidney-focused home-based care program designed to reduce hospitalizations and lower total cost of care. Transaction expected to close in late 2026 pending regulatory approvals.
- American Diabetes AssociationminorDaVita is a national sponsor of Living With Diabetes: Kidney Care from the American Diabetes Association. Partnership focuses on educating the approximately 60% of kidney failure patients who also have diabetes about the connection between these conditions and steps to protect kidney health.
- American Heart AssociationminorDaVita partners with the American Heart Association on healthcare transformation initiatives through HLTH webinars, focusing on improving health access, chronic disease management, and patient adherence. The partnership addresses cardiovascular-kidney-metabolic health connections.
- X9 (ExploraMed)minorDaVita partnered with medical device incubator ExploraMed to launch X9, developing an ultrasound-guided device to improve the cannulation process for dialysis patients. DaVita invested in X9 through its venture group with the goal of reducing cannulation-related complications and costs while improving patient outcomes. The device received FDA clearance and completed first-in-human feasibility study in November 2025.
- YMCA of the USAminorDaVita partnered with the YMCA to expand community-based health screenings and educational programs to address chronic diseases such as CKD, diabetes, and hypertension in under-resourced communities across the U.S. The initiative aims to improve early detection and long-term health outcomes by providing free screenings and engaging trusted community spaces like YMCA centers.
- MedSleuthcoreDaVita acquired transplant software company MedSleuth to enhance transplant care and increase access for patients in the U.S. The acquisition aims to streamline the transplant process, potentially increasing transplantation rates and improving patient outcomes. Deal value was undisclosed.
Scale indicators14 records
Recent moves8 records
Expansion highlights6 records
DaVita competitors and assessment
Company assessmentDirect peers
- U.S. Renal Care: U.S. Renal Care is the third-largest dialysis provider in the United States, operating outpatient dialysis centers serving patients with ESRD and CKD, with a comparable patient care model and target population to DaVita's core services.
- Satellite Healthcare: Satellite Healthcare is a leading nonprofit dialysis provider operating across multiple US states with similar outpatient center model, comparable ESRD patient population, and focus on integrated kidney care, though smaller scale than DaVita.
- Diaverum: Diaverum is a major international dialysis services provider operating across Europe, Latin America, the Middle East, and Asia, with a similar center-based dialysis care model and patient population that directly competes with DaVita International in many of the same 14 countries.
- Innovative Renal Care: Innovative Renal Care (formerly American Renal Associates) is a US-focused dialysis services provider operating outpatient centers with comparable patient population and care delivery model, competing with DaVita for patients, nephrologist partnerships, and value-based care contracts.
- Fresenius Medical Care: Fresenius Medical Care is the world's largest dialysis services and products company, operating over 4,000 dialysis centers globally and serving as DaVita's principal direct competitor in the same outpatient kidney care market across both US and international geographies.
Broad incumbents
- UnitedHealth Group / Optum: UnitedHealth Group through Optum Health is the largest US value-based care platform with growing kidney care capabilities, representing both a major DaVita partner and a potential competitor as payers expand into direct care delivery for ESRD populations.
- Humana / CenterWell: Humana through its CenterWell senior-focused primary care platform and Medicare Advantage dominance represents a major health plan partner and increasingly a care delivery competitor in value-based kidney care arrangements DaVita serves.
- HCA Healthcare: HCA Healthcare is the largest US for-profit hospital system, overlapping with DaVita on hospital discharge planning and inpatient dialysis services, and represents a key referral partner and potential vertical competitor in kidney care.
- CVS Health / Aetna: CVS Health through Aetna is a major Medicare Advantage payer and integrated care delivery player (Oak Street Health, Signify Health) with growing interest in chronic disease management, representing both a DaVita value-based care partner and potential integrated competitor.
Regional players
- Northwest Kidney Centers: Northwest Kidney Centers is a nonprofit dialysis provider primarily serving the Pacific Northwest region of the US with comparable outpatient hemodialysis services, though geographically limited and operating at smaller scale than DaVita.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
DaVita social profiles
Digital presenceDaVita compliance and trust
Trust signalCompliance3 records
DaVita financial estimates
Financial estimateRevenue estimate
Valuation estimate
DaVita leadership team
Management profileNumber of profiles
Profiles13 records
DaVita subsidiaries and ownership
Company hierarchySubsidiaries23 records
DaVita funding detail
Funding detailFunding overview
Funding rounds4 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DaVita M&A and investment
M&A and investmentM&A7 records
Investments4 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DaVita
What does DaVita do?
DaVita operates outpatient dialysis centers delivering in-center hemodialysis, in-center nocturnal dialysis, peritoneal dialysis, and home hemodialysis for patients with chronic kidney disease and end-stage renal disease. The company also provides integrated kidney care (DaVita IKC / VillageHealth), care coordination, physician solutions, transplant support via MedSleuth software, and ancillary lab and pharmacy services across the U.S. and 14 international markets.
Is DaVita a public or private company?
DaVita is a public company. It is classified as public and is currently operating.
When was DaVita founded?
DaVita was founded in 1999. It employs 5,001 to 10,000 people.
Where is DaVita based?
DaVita is headquartered in Denver, United States, in the North America region.
How does DaVita make money?
Three revenue lines are on record. Dialysis Treatment Services are the primary driver. The others are integrated Kidney Care / Value-Based Care and ancillary Services.
Who are DaVita's main competitors?
Direct peers on record are U.S. Renal Care, Satellite Healthcare, Diaverum, Innovative Renal Care and Fresenius Medical Care. Broad incumbents are UnitedHealth Group / Optum, Humana / CenterWell, HCA Healthcare and CVS Health / Aetna. Northwest Kidney Centers is listed as a regional player.
Does DaVita have an API?
No public API is recorded for DaVita.
What industry is DaVita in?
DaVita's product category is Dialysis and Kidney Care Services. Its primary akta.pro industry code is HLAFABAE, Outpatient Dialysis & Kidney Care Centers, with a secondary code of HLAKAHAC, Dialysis Services (Hemodialysis & Peritoneal Dialysis). Its NAICS code is 621492 and its SIC code is 8093.